March 5, 2020 / 10:28 PM / a month ago

BRIEF-Corvus Pharmaceuticals Reports Qtrly Loss Per Share $0.38

March 5 (Reuters) - Corvus Pharmaceuticals Inc:

* CORVUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* QTRLY LOSS PER SHARE $0.38

* EXPECTS FY 2020 NET CASH USED IN OPERATING ACTIVITIES TO BE BETWEEN $39 MILLION AND $42 MILLION

* AS OF DECEMBER 31, 2019, HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALING $78.0 MILLION

* Q4 EARNINGS PER SHARE VIEW $-0.33 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below